Bright Minds Biosciences (DRUG) Change in Accured Expenses (2022 - 2026)
Bright Minds Biosciences (DRUG) reported Change in Accured Expenses of $4011.4 for Q1 2026, down 57.62% on a YoY basis from $9464.1 in Q1 2025, and down 14.96% quarter-over-quarter from $4717.0 in Q4 2025.
Bright Minds Biosciences (DRUG) Change in Accured Expenses (2022 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Change in Accured Expenses for 5 years, with the latest figure at $4011.4 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 4,011.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,011.36 |
| Mar 31, 2026 | 4,011.36 |
| Dec 31, 2025 | 4,716.99 |
| Dec 31, 2025 | 4,716.99 |
| Jun 30, 2025 | 6,147.55 |
| Jun 30, 2025 | 6,147.55 |
| Mar 31, 2025 | 9,464.13 |
| Mar 31, 2025 | 9,464.13 |
| Dec 31, 2024 | 4,622.24 |
| Dec 31, 2024 | 4,622.24 |
| Jun 30, 2024 | -176.94 |
| Jun 30, 2024 | -176.94 |
| Mar 31, 2024 | 1,577.73 |
| Mar 31, 2024 | 1,577.73 |
| Dec 31, 2023 | 2,182.31 |
| Dec 31, 2023 | 2,182.31 |
| Jun 30, 2023 | 3,406.61 |
| Jun 30, 2023 | 3,406.61 |
| Mar 31, 2023 | 3,944.80 |
| Mar 31, 2023 | 3,944.80 |